当前位置: X-MOL 学术Mol. Imaging › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [124I]FIAU PET/CT.
Molecular Imaging ( IF 2.8 ) Pub Date : 2020-06-29 , DOI: 10.1177/1536012120936876
Steve Y Cho 1, 2 , Steven P Rowe 1 , Sanjay K Jain 3 , Lew C Schon 4, 5 , Rex C Yung 6 , Tariq A Nayfeh 7 , Clifton O Bingham 8 , Catherine A Foss 1 , Sridhar Nimmagadda 1 , Martin G Pomper 1
Affiliation  

Purpose:

Imaging is limited in the evaluation of bacterial infection. Direct imaging of in situ bacteria holds promise for noninvasive diagnosis. We investigated the ability of a bacterial thymidine kinase inhibitor ([124I]FIAU) to image pulmonary and musculoskeletal infections.

Methods:

Thirty-three patients were prospectively accrued: 16 with suspected musculoskeletal infection, 14 with suspected pulmonary infection, and 3 with known rheumatoid arthritis without infection. Thirty-one patients were imaged with [124I]FIAU PET/CT and 28 with [18F]FDG PET/CT. Patient histories were reviewed by an experienced clinician with subspecialty training in infectious diseases and were determined to be positive, equivocal, or negative for infection.

Results:

Sensitivity, specificity, positive-predictive value, negative-predictive value, and accuracy of [124I]FIAU PET/CT for diagnosing infection were estimated as 7.7% to 25.0%, 0.0%, 50%, 0.0%, and 20.0% to 71.4% for musculoskeletal infections and incalculable-100.0%, 51.7% to 72.7%, 0.0% to 50.0%, 100.0%, and 57.1% to 78.6% for pulmonary infections, respectively. The parameters for [18F]FDG PET/CT were 75.0% to 92.3%, 0.0%, 23.1% to 92.3%, 0.0%, and 21.4% to 85.7%, respectively, for musculoskeletal infections and incalculable to 100.0%, 0.0%, 0.0% to 18.2%, incalculable, and 0.0% to 18.2% for pulmonary infections, respectively.

Conclusions:

The high number of patients with equivocal clinical findings prevented definitive conclusions from being made regarding the diagnostic efficacy of [124I]FIAU. Future studies using microbiology to rigorously define infection in patients and PET radiotracers optimized for image quality are needed.



中文翻译:

[124I] FIAU PET / CT对肌肉骨骼和肺部细菌感染的评估。

目的:

在细菌感染评估中,影像学是有限的。原位细菌的直接成像有望用于无创诊断。我们调查了细菌胸苷激酶抑制剂([ 124 I] FIAU)成像肺和肌肉骨骼感染的能力。

方法:

前瞻性纳入了33例患者:疑似肌肉骨骼感染16例,疑似肺部感染14例,已知类风湿关节炎但未感染3例。31例患者接受了[ 124 I] FIAU PET / CT和28例接受了[ 18 F] FDG PET / CT的成像。病历由经验丰富的临床医生进行了传染病亚专业培训,经过审查后确定为阳性,模棱两可或阴性。

结果:

估计[ 124 I] FIAU PET / CT对感染的敏感性,特异性,阳性预测值,阴性预测值和准确性分别为7.7%至25.0%,0.0%,50%,0.0%和20.0%肌肉骨骼感染的发生率分别为71.4%和100.0%,51.7%至72.7%,0.0%至50.0%,100.0%和57.1%至78.6%,无法计算。对于[ 18 F] FDG PET / CT,肌肉骨骼感染的参数分别为75.0%至92.3%,0.0%,23.1%至92.3%,0.0%和21.4%至85.7%,不可估量为100.0%,0.0% ,肺部感染分别为0.0%至18.2%,无法计算和0.0%至18.2%。

结论:

大量临床表现模棱两可的患者无法就[ 124 I] FIAU的诊断功效做出明确的结论。未来需要使用微生物学来严格定义患者的感染情况,并需要针对图像质量进行优化的PET放射性示踪剂。

更新日期:2020-06-30
down
wechat
bug